4,4'-(1,10-Phenanthroline-3,8-diyl)dibenzoic acid

Catalog No.: 
ACQMLK629
CAS No.: 
1659300-75-0
Molecular Formula: 
C26H16N2O4
Molecular Weight: 
420.42
4,4'-(1,10-Phenanthroline-3,8-diyl)dibenzoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$183.00InquiryInquiry
250mg97%$310.00InquiryInquiry
1g97%$836.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-(1,10-Phenanthroline-3,8-diyl)dibenzoic acid
IUPAC Name4,4'-(1,10-phenanthroline-3,8-diyl)dibenzoic acid
Molecular FormulaC26H16N2O4
Molecular Weight420.42
SMILESO=C(O)C1=CC=C(C2=CC3=CC=C4C=C(C5=CC=C(C(=O)O)C=C5)C=NC4=C3N=C2)C=C1
InChI KeyRZPUEVQJLMTUFJ-UHFFFAOYSA-N
SynonymBenzoic acid, 4,?4'-?(1,?10-?phenanthroline-?3,?8-?diyl)?bis-;PTL55;4,4'-(1,10-Phenanthroline-3,8-diyl)dibenzoic acid;Benzoic acid, 4,4'-(1,10-phenanthroline-3,8-diyl)bis-
CAS No.1659300-75-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACQMLK629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNIRT390 route compound structure diagram
    ACNIRT39014047-29-1In Stock
  4. Then
  5. ACQMLK629 route product structure diagram
    ACQMLK6291659300-75-0
Inquiry

2. ACQMLK629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQMLK629 route product structure diagram
    ACQMLK6291659300-75-0
Inquiry

3. ACQMLK629 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQMLK629 route product structure diagram
    ACQMLK6291659300-75-0
Inquiry

Comments (0)